The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of licensed COVID-19 vaccinations administered as a second booster in BNT162b2 primed individuals aged 18-

Autor: McLeod, C., Dymock, M., Flanagan, KL, Plebanski, M., Marshall, HS, Estcourt, MJ, Wadia, U., Tjiam, MC, Blyth, CC, Subbarao, K., Mordant, FL, Nicholson, S., Cain, N., Brizuela, R., Faust, SN, Thornton, RB, Ellis, Z., Mckenzie, A., Marsh, JA, Snelling, TL, Richmond, PC
Zdroj: In Journal of Infection December 2024 89(6)
Databáze: ScienceDirect
Externí odkaz: